Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.

Antimicrobial agents and chemotherapy - 1 Dec 2010

Donati Manuela, Di Francesco Antonietta, D'Antuono Antonietta, Delucca Federica, Shurdhi Alisa, Moroni Alessandra, Baldelli Raffaella, Cevenini Roberto

Abstract excerpt

A systematic evaluation of the susceptibility of all Chlamydia trachomatis urogenital serovars (D through K) to levofloxacin, erythromycin, doxycycline, clarithromycin, and azithromycin was performed. All C. trachomatis serovars had comparable susceptibilities with respect to the various antimicrobials tested, thus confirming the homogeneous data so far obtained regarding the susceptibility of C. trachomatis to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Infective Agents
Share to Azithromycin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chlamydia trachomatis

Share to Clarithromycin

Share to Doxycycline

Share to Erythromycin

Share to Levofloxacin

Share to Ofloxacin

Source

Open in PubMed Open full text

Identifiers

PMID: 20855744
DOI: 10.1128/AAC.00553-10
PMCID: PMC2981272

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.PMID 20855744Read ↗

Molecular mechanisms of Chlamydia trachomatis resistance to antimicrobial drugs.Semantic proximity Read ↗

Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections.Semantic proximity Read ↗

Putative azithromycin-resistance mutations in <i>Chlamydia trachomatis</i> are globally distributed but arose before azithromycin was discoveredSemantic proximity Read ↗

Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatisSemantic proximity Read ↗

Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides.Semantic proximity Read ↗

High treatment failure rate is better explained by resistance gene detection than by minimum inhibitory concentration in patients with urogenital Chlamydia trachomatis infectionSemantic proximity Read ↗

Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained In vitro.Semantic proximity Read ↗

Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.Semantic proximity Read ↗

Rifalazil retains activity against rifampin-resistant mutants of Chlamydia pneumoniae.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.